Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schering-Plough Establishes Shanghai Operation | Contract Pharma
Breaking News

Schering-Plough Establishes Shanghai Operation

Schering-Plough has expanded its presence in China by establishing Shanghai Schering-Plough Pharmaceutical Co. Ltd. A wholly-owned operation based in Shanghai, the unit was formed through the acquisition of shares of its former joint venture partners. SP entered into an agreement in 1994 with Shanghai Pharmaceutical Industry Co., Ltd. and Shanghai Pharmaceutical Group Co., Ltd., to manufacture, market and distribute allergy and skincare products.
   
“The actions announced today are part of Schering-Plough’s long-term global geographic expansion strategy,” said Fred Hassan, chairman and chief executive officer of SP. “Investing in the Asia-Pacific Region, and especially China, represents another step in our journey to transform Schering-Plough into a global high-performance health care company. With a long-term presence in China, Schering-Plough now takes a significant step forward in its strategic development to further build growth and strength in this important market.”
   
SP in China serves Chinese health care professionals, customers and other stakeholders in the areas of allergy/respiratory, cardiovascular, central nervous system, skin care, oncology, infectious diseases, and women’s health.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters